An interventional study of Stimulation with TENS, which allows the release of endorphins and Stimulation with TENS does not allow the release of endorphins in Lower Back Pain Chronic, sponsored by University Hospital, Toulouse. Not yet recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-04.
Sponsored by University Hospital, Toulouse · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 22 studies in Pain by University Hospital, Toulouse — 5 open to participants now, 5 under way, none of them phase 3. Pain · University Hospital, Toulouse.
Among the 22 studies in Pain by University Hospital, Toulouse, this one is the 7th largest by planned enrollment of the 16 interventional ones that give a count, is one of 5 that started in 2026, is one of 9 with no phase, and was the 21st registered.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
Browse Pain studies →5 of the 22 studies in Pain by University Hospital, Toulouse are open now, in 1 country. Recruiting first, the newest first:
University Hospital, Toulouse · Sites in France
Ages 18+
University Hospital, Toulouse · Sites in France
Ages 18+ · Women only
University Hospital, Toulouse · Sites in France
Ages 18+
University Hospital, Toulouse
Ages 18+ · Women only
By country, each count listing its studies:
Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
22 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 5 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 52 is below the median of 66 across 8,512 interventional studies indexed under Pain.
Median enrollment 29 across the 16 interventional studies, 116 across the 6 observational. Of the 16 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
University Hospital, Toulouse is the lead sponsor of 809 studies on the registry; 211 are open to participants now.
2 of the studies in Pain by University Hospital, Toulouse that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07627490University Hospital, ToulouseThe Potential of Transcutaneous Electrical Nerve Stimulation to Improve Pain Experienced During Posterior Branch Blocks in Patients With Lumbar Posterior Joint Syndrome | 2026-12-01 |
| NCT07924033University Hospital, ToulousePredicting Perineal Pain During the Expulsive Phase Under Obstetric Epidural Analgesia | 2027-05 |
Add all 2 to your calendar (.ics) → With an account.
Among the 22 studies in Pain by University Hospital, Toulouse, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Procedural pain is inadequately managed in two-thirds of patients undergoing invasive medical procedures. Several techniques exist for managing procedural pain, but they all present implementation challenges and are not without side effects. Therefore, a new, non-pharmacological, inexpensive, and easy-to-use approach would be of significant benefit. Transcutaneous electrical nerve stimulation (TENS) for pain relief could represent this alternative. Few studies have been conducted on the benefits of TENS in managing procedural pain, for example, in shoulder arthrodistension. This project proposes to study it in the context of posterior ramus infiltration in patients eligible for this indication, in the context of chronic low back pain associated with posterior joint syndrome.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
for TENS:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Interventional group using TENS in gate control mode to allow the release of endorphins
Procedure: Stimulation with TENS, which allows the release of endorphins · Other: Questionnaires
Control group using TENS with placebo stimulation that does not release endorphins
Procedure: Stimulation with TENS does not allow the release of endorphins · Other: Questionnaires
Stimulation with TENS at frequencies that allow the release of endorphins before infiltration
Stimulation with TENS at levels that do not allow the release of endorphins prior to infiltration
Pain questionnaires will need to be completed at the inclusion, one month and 3 months
Comparison of the intensity of pain experienced during the infiltration procedure between the intervention group and the placebo group
Pain assessment using the visual analog scale
Time frame: 3 months after the inclusion
Evaluation of satisfaction with the infiltration procedure in both groups
Satisfaction questionnaire to be completed regarding the infiltration procedure
Time frame: 3 months after the inclusion
Comparison of the effectiveness of posterior branch block on pain in both groups
Pain questionnaires to be completed
Time frame: 3 months after the inclusion
Assessment of pain experienced by the patient in the 2 groups
Questionnaire on the reduction of perceived pain
Time frame: 3 months after the inclusion
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Sep 2026; primary completion for Dec 2026, 3 months later.
Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 3 months is below that.
Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Toulouse →